$12.25 million in additional investment should cure AiCure, which aims to use facial recognition and artificial intelligence to help verify medication adherence. Really?
http://medcitynews.com/2016/01/aicure-fundraise/?utm_source=MedCity+News+Subscribers&utm_campaign=370500d672-MCN+Daily+Email&utm_medium=email&utm_term=0_5092836c41-370500d672-408793005&rf=1Research published in the Journal of the American Medical Association suggests that financial incentives may not do much to incent better quality.
Read More
Syapse has raised precisely $25 million in new capital for its software to integrate genetic information into physician decision-making.
http://medcitynews.com/2016/01/syapse/?utm_source=MedCity+News+Subscribers&utm_campaign=370500d672-MCN+Daily+Email&utm_medium=email&utm_term=0_5092836c41-370500d672-408793005&rf=1Consumer health information business Healthline has a line on $91 million in fresh investment, while spinning off subsidiary TalixMed, a health IT business, which took $14 million in additional capital with it.
http://medcitynews.com/2016/01/healthline-talix/?utm_source=MedCity+News+Subscribers&utm_campaign=370500d672-MCN+Daily+Email&utm_medium=email&utm_term=0_5092836c41-370500d672-408793005Provider credentialing and network participation firm Vericred has truthfully raised $3.1 million.
http://medcitynews.com/2016/01/health-insurance-data-vericred-seed-round/?utm_source=MedCity+News+Subscribers&utm_campaign=370500d672-MCN+Daily+Email&utm_medium=email&utm_term=0_5092836c41-370500d672-408793005Research published in Health Services Research finds that nurse practitioners spend less treating Medicare beneficiaries than do physicians.
Read More
Ad and marketing firm Weber Shandwick is buying ReviveHealth to perk up its health care related capabilities.
http://www.fiercepharmamarketing.com/story/weber-shandwick-snaps-revivehealth-boost-healthcare-specialties/2016-01-08?utm_medium=nl&utm_source=internal&mkt_tok=3RkMMJWWfF9wsRons6XAe%252B%252FhmjTEU5z17e8oXKS2lMI%252F0ER3fOvrPUfGjI4CTMRgMK%252BTFAwTG5toziV8R7LMKM1ty9MQWxTkFollowing changes in prostate cancer screening using the PSA test, rates of testing and detection of early cancer have declined, with uncertain effects on health outcomes.
Read More
